chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Developed shingles from the shot.  Raised abrasions/rash on right ribcage from middle of stomach around to middle of back on the right side.  Nerve pain followed abrasions and lasted for 3 weeks. PCP and Infectious Disease Physician both confirmed it was shingles.  They placed me on gabapentin and valcyclovir (3G/Day) for 7 days.  It took 3 weeks for the symptoms to lessen.
My menstrual cycles have been completely screwed up.  Three weeks to a month to two weeks or more this time.  This vaccine has affected my hormones and menstrual cycle.  I will now have to consult with my primary this month and incur costs associated with this.
HAD REACTION TO THE SECOND COVID SHOT; FELT HOT; BLISTER ON FOOT; ARM BLEW UP; Received booster dose in less than 3 month afer receiveing 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (HAD REACTION TO THE SECOND COVID SHOT), VACCINATION SITE WARMTH (FELT HOT), BLISTER (BLISTER ON FOOT), VACCINATION SITE SWELLING (ARM BLEW UP) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received booster dose in less than 3 month afer receiveing 2nd dose) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis and Crohn's disease.    No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. On 19-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received booster dose in less than 3 month afer receiveing 2nd dose). On an unknown date, the patient experienced IMMUNISATION REACTION (HAD REACTION TO THE SECOND COVID SHOT), VACCINATION SITE WARMTH (FELT HOT), BLISTER (BLISTER ON FOOT) and VACCINATION SITE SWELLING (ARM BLEW UP). At the time of the report, IMMUNISATION REACTION (HAD REACTION TO THE SECOND COVID SHOT), VACCINATION SITE WARMTH (FELT HOT), BLISTER (BLISTER ON FOOT) and VACCINATION SITE SWELLING (ARM BLEW UP) had resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received booster dose in less than 3 month afer receiveing 2nd dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No concomitant medications were reported. No treatment medications were reported.
A consumer report has been received. The report concerns a 43 year old, Female patient. The patient's concurrent diseases included chronic neck pain and chronic lower back pain. Concomitant medications included cetirizine for allergies. The patient received nasal FLUMIST of Lot no. AJ2141, 0.2 millilitres, once/single administration on 23-Oct-2012. Patient received FLUMIST in Nov 2010 and 18-Oct-2011 with no adverse event/effect. The patient experienced moderate nausea, moderate overall weakness, moderate muscle ache and moderate tiredness which started on 28-Oct-2012, moderate headaches which started on 24-Oct-2012. The patient also experienced neck pain and back pain. At the time of reporting the events of nausea, headaches overall weakness, muscle ache and tiredness were recovering. The outcome of the events of neck pain and back pain was unknown. The company physician assessed the events of headaches, to be serious due to disability. The company physician assessed the events of overall weakness, muscle ache and tiredness to be serious with seriousness criteria of important medical event. The events of neck pain and back pain assessed to be non serious.
Information has been received from a registered nurse concerning an 18 year old female who on 04/11/2001 was vaccinated with the first dose of the varicella vaccine. There was no concomitant medication. A few days after vaccination, the pt developed five to 10 lesions and lethargy. Unspecified medical attention was sought. The lesions scabbed and crusted and her symptoms subsided. Additional info has been requested.
Shot administered in upper left arm.  Reaction includes redness and extreme swelling of arm from 1" above injection to elbow (about 5" below injection), and wrapping around to back/underside of arm.  The entire area is red, swollen, hot, and hard to the touch.  Patient is complaining of itchiness in entire area.
There was no adverse reaction but the patient was under the age of 18. She was vaccinated at an offsite clinic. She was turned away at least once but slipped back in and was vaccinated by someone who checked the year but not the month and date before vaccinating her. Her father was present and was vaccinated as well and was part of the push to get her sent back through.
On June 13, I spontaneously had a severe pain in my right calf that ended up being a superficial blood clot. I have had clots before but only ever during pregnancy and this was 10.5 months postpartum
fatigue; chills; hot flashes; headache; insomnia; This is a spontaneous report from a contactable 50-year-old male consumer reported that a 50-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Age at vaccination: 50 Years), dose 2 via an unspecified route of administration, administered in Arm Right on 11Feb2021 13:00 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included hypertension. Concomitant medications included amlodipine besilate (NORVASC); telmisartan (MICARDIS); zinc; VITAMIN C [ASCORBIC ACID]; vitamin d nos. The patient previously received first single dose of bnt162b2 on Right arm on 21Jan2021,11:00 single (Age at vaccination: 50 Years) for Covid-19 immunization. the patient not receive any other vaccines within 4 weeks prior to the COVID vaccine; List of any other medications the patient received within 2 weeks of vaccination: Norvasc, Micardis, multivitamin, vitamin C+D+zinc. On 11Feb2021 21:15, patient had fatigue, chills, hot flashes, headache, insomnia. Patient received treatment with Advil. Prior to vaccination, the patient not diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
6 days after receiving my initial covid vaccine, I began to develop an itchy rash. The rash started in the morning of 12/28/2020, beginning with itchy, red ankles. Progressed over the next 8 hours over my whole body. Red, raised, itchy patches. No other associated symptoms and no other means of explaining allergic reaction (no new meds, foods, clothing, detergents). Left work, took Benadryl and a shower. Rash subsided. I feel fine today.
I felt very sick for the first 24 hours and it went away.; I experienced the worst herpes outbreak of my life.; I experienced the worst herpes outbreak of my life. Lasted 3+ weeks and was very painful.; It left painful scar tissue and I struggle with intimacy now; 1st dose on 16Mar2021 and 2nd dose on 30Mar2021; This is a spontaneous report from a contactable consumer. A 28-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in left arm on 30Mar2021 at 13:00 (at the age of 28-years-old) as DOSE 2, SINGLE for COVID-19 immunization. Medical history included drug hypersensitivity (Known allergies: had some poor reactions to some antibiotics) from an unknown date and unknown if ongoing. Asthma and gastrooesophageal reflux disease (GERD) from an unknown date and unknown if ongoing. No concomitant medication was reported. Historical vaccine included: first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported) as dose 1, single administered in right arm on 16Mar2021 at 13:00 for COVID-19 immunization. No COVID prior vaccination. No other vaccine in four weeks. No other medications in two weeks. Facility type vaccine reported as other. On 02Apr2021 at 13:00, the patient felt very sick for the first 24 hours and it went away. Shortly after, patient experienced the worst herpes outbreak of life. Lasted 3+ weeks and was very painful. Patient was recovered but it was very scary. It left painful scar tissue and struggle with intimacy now. Had not reported because patient was so embarrassed. Was urged by a friend to report. Adverse event resulted in: Disability or permanent damage. If patient recovered: Recovered with lasting effects. No treatment received for the adverse event. No COVID tested post vaccination. The outcome of the event inappropriate schedule of vaccine administered was unknown while other events were recovered on 2021.   Information on the lot/batch number has been requested.
Patient received her 1st dose of Covid-19 vaccine, Lot #ER2613, in her left deltoid on 3/25/2021 approximately 11:53am at the Vaccination Clinic at the Medical Center. While waiting in the parking lot, patient honked her horn and alerted medics she was not feeling well. Reaction occurred at approximately 12:40pm. Patient had tongue swelling, racing heart, and lightheadedness. Medics took vital signs and administered 0.3ml Epinephrine IM. Patient was transported to Medical Center.
Chills, shivers, muscle pain, severe back pain, felt like I had fever although I did not take my temperature
fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and CHILLS (chills) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Sleep walking (She had one episode of sleep walking 40 years ago, but has no history of sleep walking since then).    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever) and CHILLS (chills). At the time of the report, PYREXIA (fever) and CHILLS (chills) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient was on concomitant medications, but did not specify the names. No treatment medications were reported.   This case was linked to MOD-2022-535838, MOD-2022-535842, MOD-2022-535849 (Patient Link).
This spontaneous report as received from a pharmacist refers to a 65 year old male patient. Patient's concurrent conditions included unspecified heart condition, diabetes and pre-existing left shoulder condition. On 03-NOV-2014 the patient was vaccinated with a dose of ZOSTAVAX dose and route not reported, in right deltoid region (lot # K010648, expiration date: 30-OCT-2015). On an unspecified date in November 2014, after receiving ZOSTAVAX, the patient developed local injection site reaction with redness and tenderness. Additionally patient had nausea. On 04-NOV-2014 the patient received unspecified steroid injection in left shoulder to treat pre-existing unspecified shoulder condition. On 04-NOV-2014 the patient experienced episode of vomiting once. The patient did not seek medical attention. No treatment was given for the events. The outcome of nausea, local injection site reaction with redness and tenderness was reported as not recovered/not resolved. Relatedness between the events and ZOSTAVAX was not provided. Additional information has been requested.
Pt c/o headache for 48 hrs /p vax of Engerix B, treated /w Demerol, resolved
Two days after the vaccination, patient had persistent fever of (104).  On the third day, had seizure due to fever. On day fifth, patient had generalized rash. Mild and moderate reactions.
had a sore arm and was achy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 30-year-old male patient received BNT162b2 (BNT162B2), in Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 30 years for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing), notes: Diagnosed pre-2020 and reporter would say maybe in 2018 patient he was undiagnosed. Concomitant medication(s) included: LEVOTHYROXINE taken for hypothyroidism. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: Feb2021, when the patient was 30 years old, for COVID-19 immunization, reaction(s): "had a sore arm and was achy". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "had a sore arm and was achy". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: The patient's medical history was reported as: Hypothyroidism was diagnosed pre-2020 and reporter would say maybe in 2018 as patient was undiagnosed and after the fact he noted his hands were cold and put it together it may be the hypothyroidism and so was getting treatment by 2018 and this started to appear when the patient was in law school in 2016 and he was treated and they thought he was not just tired from law school but attributed some fatigue to being in school so was diagnosed in 2017 or 2018 for the hypothyroidism. Reporter further stated that the patient mounted a response and he had said his arms were a little sore; clarified the patient had a sore arm and was achy and was unremarkable.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300249456 same reporter/patient/product, different dose/event;US-PFIZER INC-202300249538 same reporter/patient/product, different dose/event;
Approximately 8 hrs. after injection began to have severe chills, bundled up, took sleeping pill and went to sleep. Woke multiple times during night with aching muscles and joints. Early AM awoke with chills gone but increased body ache, temp 99.8, headache. Symptoms persisted during that day and evening  with feeling of total fatigue which kept me in bed all day.  Tylenol 500mg. gave some relief. Slept better that night and were improved enough to return home.
Frontal headache with associated nausea x 4 days following vaccine. 7/10 on pain scale Tx: 800 mg Advil
This patient had come in today for a shot only visit. He was given Hepatitis A, Hepatitis B, and Gardasil injections. A time out was completed and allergies were verified. Mom reported no hx of reactions to vaccines. The patient was asked to remain in clinic for 15 minutes following the injections. They agreed to do so. At 1010, approximately 5 mins post-injection, the accompanying  interpreter approached the nurse at the nurses station and reported that the patient presented with pallor and c/o nausea and dizziness. The nurse responded to the patient room and observed the pallor. The patient also c/o nausea. A cold cloth was placed on the patients neck and he was asked to remain seated. Vitals were 113/71 Pulse 65, Respirations 18 and O2 Sat 98%. The patient had not eaten breakfast. Dr. precepting attending was asked to observe the patient in clinic. He spoke with both the patient and the patients mother briefly. A plan was set in place to give the patient a light snack and have him sit down a while longer to ensure safety until he felt better and could go home. The patient ate the snack and tolerated it well. No vomiting was observed. The pt reported that he felt better after approximately 15-20 more minutes. The patient was sent home.
Deltoid muscle swollen and feels hot to touch - pt instructed to put ice on area and to contact her PCP.
Pt calls to report red area, approx size of baseball, to left arm where he received TDAP. TDAP administered 9/15/12 & pt first noticed today, 9/17/12. Advised ice & anti-inflammatories, come in to office if no better.
Patient's arm started to swell a few hours after the vaccine was administered. It swelled significantly large. She came in that night to show the pharmacy staff. It was the upper arm that had swollen. Later, she said the lower part of her arm was swollen.
On 8/30/00, on the date of his birth, the pt received his 1st Engerix-B. The pt was discharged from the hospital on approx. 9/8/00 and 1 week later, approx. 9/15/00, the pt developed an URI with fever of 101F to 102F (ear). The pt was seen by a pediatrician and was given unspecified antibiotic and liquid Tylenol. The URI resolved within 1 week. Two weeks later, approx. 10/1/00, the pt developed discoloration around his lips and mouth; a "few days" later, he developed petechia "all over". These symptoms resolved before 10/23/00. On 10/23/00, the pt received his 2nd dose of Engerix-B, DPT and IPV and within hours, post vax, the pt began to "cry all the time". The pt was seen twice by a pediatrician who made a dx of colic. The infant was then seen at a nearby clinic, due to colic and a swollen tongue. The colic was treated with hyoscyamine sulfate 2 to 4 drops every 6 hours. On 11/22/00, the pt went into respiratory arrest. He was taken by EMS to the local hospital, then transferred to a tertiary care center. The pt was hospitalized until 12/20/00 and, upon discharge, was placed in a foster home. The father was charged with shaken baby syndrome and the mother was charged with neglect. As of 2/26/01, the pt has "brain damage and is totally blind and deaf as a result of respiratory arrest."
Redness, itching, rash, on wrist where 3M micropore tape was adhered to skin. The tape had been used daily for scar management post-surgery for 4 weeks before vaccine. No reaction to tape adhesive until 1 day after vaccine.
Felt like hot liquid. Increased blood sugars. Diarrhea. Shakey feeling, like caffeine high.
Initially warm swollen redness with knot headache on days 2 thru 4. Jan 8 swelling worse with redness and itching. Symptoms relieved with benadyrl. Day 14 redness rash hot burning to touch. Area spread around arm approx 4 inches wide.  . Sent to urgent care. Given steroids and antibiotics.
Patient was vaccinated on 1/30/09 after falling on the ice. After the vaccine she called complaining of redness and pain at the injection site (rt arm). She was seen on  2/2/09 and 2/3/09 and had moderate erythema, induration, and pain at the injection site (approx 3 inches x 4 inches). She was advised to apply ice and take Ibuprofen for the pain. She did not have any respiratory complaints during these visits.   She reports that she went to the emergency room 2/6/09 and 2/8/09 with acute asthma exacerbation, peak flows initially less than 200 and improved to 350. She states that through the week she had experienced fever, difficulty breathing, wheezing, paleness, weakness and extreme tiredness. She was seen again at our health center on 2/9/09 with peak flows in the 300-350 range. The hospital started her on a course of prednisone and she was using albuterol by nebulizer and Proair inhaler. She was stable on Monday and will return to our health center today for re-evaluation.
Pfizer-BioNTech COVID-19 Vaccine EUA: patient hospitalized for rhabdomyolysis, myositis, and myocarditis/pericarditis after starting checkpoint inhibitors while taking atorvastatin and recently received third dose of COVID-19 vaccination. Event attributed to checkpoint inhibitors. Patient received hemodialysis, steroids, and IVIG and improved. Discharged to home medically stable.
CLITORIS THE SIZE OF A PINEAPPLE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. he patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination.The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers."No concomitant medications were reported. On APR-2021, the subject experienced clitoris the size of a pineapple. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from clitoris the size of a pineapple. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard procedure as the case assessed as non-serious.
Pt vaccinated on 9/9/16 on 9/22 pt was seen for pain at injection site, had an area of vesicular rash with surrounding erythema, also runny nose, cough and malaise treated with valacyclovir 500mg 2 tabs TID x 7 days.
This spontaneous report received from a registered nurse referred to a 1 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 06-MAR-2017, the patient was vaccinated with VARIVAX (dose, frequency not reported, lot:M035142, expiry date not reported) for an unspecified indication. The nurse reported that the vaccines were stored in a freezer with defrost cycles, but full excursion details were not provided (incorrect product storage). The reason for the temperature excursion occurred was due to the defrost cycle of the freezer. The nurse was unable to provide the lot number and expiration date for the properly stored sterile diluent that may have been used to reconstitute the vaccine. No adverse effects reported. The temperature for the vaccine stored and time frame was unspecified. Previous temperature excursion was unspecified. Data logger was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Patient received vaccine at 2:13 PM and waited in the pharmacy for 30 minutes based on allergy history. Patient felt fine when she left the pharmacy and headed home. 20-30 minutes after she left the pharmacy she began to feel that she was having trouble swallowing and eventually noticed that she was having trouble breathing and had bumps on her tongue as well as swollen lips. She drove to the ER and arrived at 3:50 PM where they administered her EpiPen along with benadryl and prednisone. She felt better within 15-20 minutes of EpiPen administration and remained in the hospital for 4 hours until her blood pressure was stable. She is still taking prednisone and has not had any other issues since ER discharge.
Five or six times throughout the day I had a racing heartbeat and once or twice I felt light-headed.  11/3/09:  Vaccine record received, lot number updated in VAERS, manufacturer not provided.   11/3/09:  Prenatal records received, patient is a G3 P1 with an EDD of 12/07/09, no mention is made of an adverse event in the records.
Dizziness, vomiting, blurred vision, fever, chills, sweats. Lasted about 5 hours.
Mom reports MENVEO site is swollen to size of baseball/softball, swelling and increased warm, advised BENADRYL, ice area and to call Monday if area not any better.
Approximately 5-6 days after the second vaccine I started developing Tinnitus with pressure in ears/head.  As of today (5/5/2021),  approx. 11 days,  it has not improved and may be getting worse